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EXPERIENCE WITH GESTONORONE CAPROATE （SH－582）
         IN PROSTATIC HYPERTROPHY
Hiroエni TANAKA and Tsuneo SHIRAIsHI
From the DePartment of Urology， Z／iroshima University Medical School
  Gestonorone caproate supplied by Schering A．G． was used in the treatment of 35 patients
with prostatic hypertrophy diagnosed by clinical observation， rectal examination， cystoure－
thrography and x－ray examination （13 in the initial stage， 9 in the second stage and 13 in
the third stage）． The clinical effects obtained especially on residual urine volume and uro－

















    Table 1． Study patients．
Benign Prostatic Hypertrophy































Table 2． Changes of clinical complaints．
             （After 1 month）
Table 4．Results of uroflowmetric examination．
          （After 3 months）
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Force of stream； Dysuria．
Table 3． Results of residual urine．










＊ 4 cases： operation．
Volume void； Flow rate．
Maximal fiow ； Average fiow．
Table 5． Summary of results．
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